Subarachnoid hemorrhage in the African-American population: A cooperative study

Gary C. Dennis, Babu Welch, Arthur N. Cole, Raphael Mendoza, Jay Morgan, Joseph Epps, Estrada Bernard, Phillip St Louis

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The clinical outcome of patients following subarachnoid hemorrhage is complicated by delayed cerebral ischemia and contributing factors such as hypertension. To observe the impact of hypertension and delayed cerebral ischemia on the outcome of a predominantly African-American cohort following subarachnoid hemorrhage, both retrospective (n=42) and prospective (n=21) studies were conducted. In the total pool (n=63), the mean age was 49.7 years (range: 17 to 80) with a preponderance of female patients (70%). Aneurysm formation was significant in the region of the posterior communicating artery. Of the patients reviewed, 73.8% had preexisting hypertension and 45.9% developed delayed cerebral ischemia. Approximately 89% of the patients who suffered from delayed cerebral ischemia had hypertension. Results failed to display any significant beneficial association between the use of the calcium channel blocker nimodipine and delayed cerebral ischemia. Use of the antifibrinolytic drug aminocaproic acid demonstrated a worse patient outcome. It is not recommended that aminocaproic acid be used in this population. Subsequently, due to the proportional occurrence of delayed cerebral ischemia in hypertensive patients following subarachnoid hemorrhage, it is suggested that prophylactic surgical management of unruptured intracranial aneurysms be considered in hypertensive patients. Further study is needed to discern the association between hypertension, delayed cerebral ischemia, and stroke in patients following subarachnoid hemorrhage.

Original languageEnglish (US)
Pages (from-to)101-108
Number of pages8
JournalJournal of the National Medical Association
Volume89
Issue number2
StatePublished - Feb 1997

Fingerprint

Subarachnoid Hemorrhage
African Americans
Brain Ischemia
Population
Hypertension
Aminocaproic Acid
Nimodipine
Antifibrinolytic Agents
Calcium Channel Blockers
Intracranial Aneurysm
Aneurysm
Arteries
Stroke
Pharmaceutical Preparations

Keywords

  • African Americans
  • Cerebral ischemia
  • Hypertension
  • Subarachnoid hemorrhage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dennis, G. C., Welch, B., Cole, A. N., Mendoza, R., Morgan, J., Epps, J., ... St Louis, P. (1997). Subarachnoid hemorrhage in the African-American population: A cooperative study. Journal of the National Medical Association, 89(2), 101-108.

Subarachnoid hemorrhage in the African-American population : A cooperative study. / Dennis, Gary C.; Welch, Babu; Cole, Arthur N.; Mendoza, Raphael; Morgan, Jay; Epps, Joseph; Bernard, Estrada; St Louis, Phillip.

In: Journal of the National Medical Association, Vol. 89, No. 2, 02.1997, p. 101-108.

Research output: Contribution to journalArticle

Dennis, GC, Welch, B, Cole, AN, Mendoza, R, Morgan, J, Epps, J, Bernard, E & St Louis, P 1997, 'Subarachnoid hemorrhage in the African-American population: A cooperative study', Journal of the National Medical Association, vol. 89, no. 2, pp. 101-108.
Dennis, Gary C. ; Welch, Babu ; Cole, Arthur N. ; Mendoza, Raphael ; Morgan, Jay ; Epps, Joseph ; Bernard, Estrada ; St Louis, Phillip. / Subarachnoid hemorrhage in the African-American population : A cooperative study. In: Journal of the National Medical Association. 1997 ; Vol. 89, No. 2. pp. 101-108.
@article{bc86644b459f4fe7b69e0ed15a7d01fb,
title = "Subarachnoid hemorrhage in the African-American population: A cooperative study",
abstract = "The clinical outcome of patients following subarachnoid hemorrhage is complicated by delayed cerebral ischemia and contributing factors such as hypertension. To observe the impact of hypertension and delayed cerebral ischemia on the outcome of a predominantly African-American cohort following subarachnoid hemorrhage, both retrospective (n=42) and prospective (n=21) studies were conducted. In the total pool (n=63), the mean age was 49.7 years (range: 17 to 80) with a preponderance of female patients (70{\%}). Aneurysm formation was significant in the region of the posterior communicating artery. Of the patients reviewed, 73.8{\%} had preexisting hypertension and 45.9{\%} developed delayed cerebral ischemia. Approximately 89{\%} of the patients who suffered from delayed cerebral ischemia had hypertension. Results failed to display any significant beneficial association between the use of the calcium channel blocker nimodipine and delayed cerebral ischemia. Use of the antifibrinolytic drug aminocaproic acid demonstrated a worse patient outcome. It is not recommended that aminocaproic acid be used in this population. Subsequently, due to the proportional occurrence of delayed cerebral ischemia in hypertensive patients following subarachnoid hemorrhage, it is suggested that prophylactic surgical management of unruptured intracranial aneurysms be considered in hypertensive patients. Further study is needed to discern the association between hypertension, delayed cerebral ischemia, and stroke in patients following subarachnoid hemorrhage.",
keywords = "African Americans, Cerebral ischemia, Hypertension, Subarachnoid hemorrhage",
author = "Dennis, {Gary C.} and Babu Welch and Cole, {Arthur N.} and Raphael Mendoza and Jay Morgan and Joseph Epps and Estrada Bernard and {St Louis}, Phillip",
year = "1997",
month = "2",
language = "English (US)",
volume = "89",
pages = "101--108",
journal = "Journal of the National Medical Association",
issn = "1943-4693",
publisher = "National Medical Association",
number = "2",

}

TY - JOUR

T1 - Subarachnoid hemorrhage in the African-American population

T2 - A cooperative study

AU - Dennis, Gary C.

AU - Welch, Babu

AU - Cole, Arthur N.

AU - Mendoza, Raphael

AU - Morgan, Jay

AU - Epps, Joseph

AU - Bernard, Estrada

AU - St Louis, Phillip

PY - 1997/2

Y1 - 1997/2

N2 - The clinical outcome of patients following subarachnoid hemorrhage is complicated by delayed cerebral ischemia and contributing factors such as hypertension. To observe the impact of hypertension and delayed cerebral ischemia on the outcome of a predominantly African-American cohort following subarachnoid hemorrhage, both retrospective (n=42) and prospective (n=21) studies were conducted. In the total pool (n=63), the mean age was 49.7 years (range: 17 to 80) with a preponderance of female patients (70%). Aneurysm formation was significant in the region of the posterior communicating artery. Of the patients reviewed, 73.8% had preexisting hypertension and 45.9% developed delayed cerebral ischemia. Approximately 89% of the patients who suffered from delayed cerebral ischemia had hypertension. Results failed to display any significant beneficial association between the use of the calcium channel blocker nimodipine and delayed cerebral ischemia. Use of the antifibrinolytic drug aminocaproic acid demonstrated a worse patient outcome. It is not recommended that aminocaproic acid be used in this population. Subsequently, due to the proportional occurrence of delayed cerebral ischemia in hypertensive patients following subarachnoid hemorrhage, it is suggested that prophylactic surgical management of unruptured intracranial aneurysms be considered in hypertensive patients. Further study is needed to discern the association between hypertension, delayed cerebral ischemia, and stroke in patients following subarachnoid hemorrhage.

AB - The clinical outcome of patients following subarachnoid hemorrhage is complicated by delayed cerebral ischemia and contributing factors such as hypertension. To observe the impact of hypertension and delayed cerebral ischemia on the outcome of a predominantly African-American cohort following subarachnoid hemorrhage, both retrospective (n=42) and prospective (n=21) studies were conducted. In the total pool (n=63), the mean age was 49.7 years (range: 17 to 80) with a preponderance of female patients (70%). Aneurysm formation was significant in the region of the posterior communicating artery. Of the patients reviewed, 73.8% had preexisting hypertension and 45.9% developed delayed cerebral ischemia. Approximately 89% of the patients who suffered from delayed cerebral ischemia had hypertension. Results failed to display any significant beneficial association between the use of the calcium channel blocker nimodipine and delayed cerebral ischemia. Use of the antifibrinolytic drug aminocaproic acid demonstrated a worse patient outcome. It is not recommended that aminocaproic acid be used in this population. Subsequently, due to the proportional occurrence of delayed cerebral ischemia in hypertensive patients following subarachnoid hemorrhage, it is suggested that prophylactic surgical management of unruptured intracranial aneurysms be considered in hypertensive patients. Further study is needed to discern the association between hypertension, delayed cerebral ischemia, and stroke in patients following subarachnoid hemorrhage.

KW - African Americans

KW - Cerebral ischemia

KW - Hypertension

KW - Subarachnoid hemorrhage

UR - http://www.scopus.com/inward/record.url?scp=0031065293&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031065293&partnerID=8YFLogxK

M3 - Article

C2 - 9046763

AN - SCOPUS:0031065293

VL - 89

SP - 101

EP - 108

JO - Journal of the National Medical Association

JF - Journal of the National Medical Association

SN - 1943-4693

IS - 2

ER -